Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Aug. 12, 2015

View Archived Issues

Google Expands Health Care Reach: Google continues deep dive into health care with Dexcom partnership

Google/Alphabet (NASDAQ:GOOG) (Mountain View, Calif.) continues to make its push into health care. Read More

Bucking convention: Conformis makes a name for itself, sees Q2 revenue jump to $19.2 million

Inside the Beltway: Clinical lab group not ruling out lawsuit against FDA over lab test regulations

MDD Interview: Quanta's high-flow, in-home therapy is set to disrupt hemodialysis market

Agreements/contracts: Entellus to distribute Fiagon's imaging for ENT procedures

HIT Bits: Haemonetics launches HaemoCloud for blood management connectivity

Financings: Therox gets $16.8M funding despite failed IPO and PMA

people in places

Daily M&A: One Call Care Management completes Medfocus acquisition

Briefly noted

Briefly Noted

Products

MDD's Oncology Extra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...